Compile Data Set for Download or QSAR
maximum 50k data
Found 242 with Last Name = 'natala' and Initial = 'sr'
TargetTyrosine-protein kinase SYK(Homo sapiens (Human))
Takeda California

Curated by ChEMBL
LigandPNGBDBM50204291(CHEMBL3953104 | US20230295171, Example 76)
Affinity DataIC50:  0.5nMAssay Description:Inhibition of human C-terminal 6His-tagged SYK (356 to 635 residues) expressed in Sf9 insect cells using 5-carboxyfluorescein(FAM)-EEPLYWSFPAKKK-NH2 ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTyrosine-protein kinase SYK(Homo sapiens (Human))
Takeda California

Curated by ChEMBL
LigandPNGBDBM50204296(CHEMBL3941633 | US20230295171, Example 75)
Affinity DataIC50:  0.800nMAssay Description:Inhibition of human C-terminal 6His-tagged SYK (356 to 635 residues) expressed in Sf9 insect cells using 5-carboxyfluorescein(FAM)-EEPLYWSFPAKKK-NH2 ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTyrosine-protein kinase SYK(Homo sapiens (Human))
Takeda California

Curated by ChEMBL
LigandPNGBDBM620222(BDBM50204292 | US20230295171, Example 82)
Affinity DataIC50:  0.900nMAssay Description:Inhibition of human C-terminal 6His-tagged SYK (356 to 635 residues) expressed in Sf9 insect cells using 5-carboxyfluorescein(FAM)-EEPLYWSFPAKKK-NH2 ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetTyrosine-protein kinase SYK(Homo sapiens (Human))
Takeda California

Curated by ChEMBL
LigandPNGBDBM50204293(CHEMBL3983415 | US20230295171, Example 25)
Affinity DataIC50:  1.10nMAssay Description:Inhibition of human C-terminal 6His-tagged SYK (356 to 635 residues) expressed in Sf9 insect cells using 5-carboxyfluorescein(FAM)-EEPLYWSFPAKKK-NH2 ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTyrosine-protein kinase SYK(Homo sapiens (Human))
Takeda California

Curated by ChEMBL
LigandPNGBDBM50204290(CHEMBL3979920 | US11077111, Compound IIIa | US2023...)
Affinity DataIC50:  2nMAssay Description:Inhibition of human recombinant full length N-terminal GST-tagged SYK cytoplasmic domain expressed in baculovirus expression system by Z'-LYTE assayMore data for this Ligand-Target Pair
TargetTyrosine-protein kinase SYK(Homo sapiens (Human))
Takeda California

Curated by ChEMBL
LigandPNGBDBM50204295(CHEMBL3944381)
Affinity DataIC50:  2.30nMAssay Description:Inhibition of human C-terminal 6His-tagged SYK (356 to 635 residues) expressed in Sf9 insect cells using 5-carboxyfluorescein(FAM)-EEPLYWSFPAKKK-NH2 ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTyrosine-protein kinase SYK(Homo sapiens (Human))
Takeda California

Curated by ChEMBL
LigandPNGBDBM50204288(CHEMBL3925430 | US20230295171, Example 88)
Affinity DataIC50:  3.10nMAssay Description:Inhibition of human C-terminal 6His-tagged SYK (356 to 635 residues) expressed in Sf9 insect cells using 5-carboxyfluorescein(FAM)-EEPLYWSFPAKKK-NH2 ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTyrosine-protein kinase SYK(Homo sapiens (Human))
Takeda California

Curated by ChEMBL
LigandPNGBDBM50204290(CHEMBL3979920 | US11077111, Compound IIIa | US2023...)
Affinity DataIC50:  3.20nMAssay Description:Inhibition of human C-terminal 6His-tagged SYK (356 to 635 residues) expressed in Sf9 insect cells using 5-carboxyfluorescein(FAM)-EEPLYWSFPAKKK-NH2 ...More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein kinase FLT3(Homo sapiens (Human))
Takeda California

Curated by ChEMBL
LigandPNGBDBM50204290(CHEMBL3979920 | US11077111, Compound IIIa | US2023...)
Affinity DataIC50:  4.60nMAssay Description:Inhibition of human N-terminal 6His-tagged FLT3 (564 to 993 residues) expressed in Sf9 insect cells using 5-carboxyfluorescein(FAM)-KKKKEEIYFFFG-NH2 ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTyrosine-protein kinase SYK(Homo sapiens (Human))
Takeda California

Curated by ChEMBL
LigandPNGBDBM50204289(CHEMBL3892927 | US20230295171, Example 13)
Affinity DataIC50:  4.70nMAssay Description:Inhibition of human C-terminal 6His-tagged SYK (356 to 635 residues) expressed in Sf9 insect cells using 5-carboxyfluorescein(FAM)-EEPLYWSFPAKKK-NH2 ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTyrosine-protein kinase SYK(Homo sapiens (Human))
Takeda California

Curated by ChEMBL
LigandPNGBDBM50204294(CHEMBL3943295 | US20230295171, Example 8)
Affinity DataIC50:  13nMAssay Description:Inhibition of human C-terminal 6His-tagged SYK (356 to 635 residues) expressed in Sf9 insect cells using 5-carboxyfluorescein(FAM)-EEPLYWSFPAKKK-NH2 ...More data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase receptor Ret(Homo sapiens (Human))
Takeda California

Curated by ChEMBL
LigandPNGBDBM50204290(CHEMBL3979920 | US11077111, Compound IIIa | US2023...)
Affinity DataIC50:  19nMAssay Description:Inhibition of human recombinant GST-tagged RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus expression system by Z'-LYTE assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEphrin type-A receptor 1(Homo sapiens (Human))
Takeda California

Curated by ChEMBL
LigandPNGBDBM50204290(CHEMBL3979920 | US11077111, Compound IIIa | US2023...)
Affinity DataIC50:  31nMAssay Description:Inhibition of human recombinant GST-tagged EPHA1 cytoplasmic domain (568 to 976 residues) expressed in baculovirus expression system by Z'-LYTE assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase Chk1(Homo sapiens (Human))
Takeda California

Curated by ChEMBL
LigandPNGBDBM50204290(CHEMBL3979920 | US11077111, Compound IIIa | US2023...)
Affinity DataIC50:  50nMAssay Description:Inhibition of human recombinant full length His-tagged CHK1 expressed in baculovirus expression system by Z'-LYTE assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTyrosine-protein kinase Fer(Homo sapiens (Human))
Takeda California

Curated by ChEMBL
LigandPNGBDBM50204290(CHEMBL3979920 | US11077111, Compound IIIa | US2023...)
Affinity DataIC50:  51nMAssay Description:Inhibition of human recombinant FER cytoplasmic domain (541 to 822 residues) expressed in baculovirus expression system by Z'-LYTE assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTyrosine-protein kinase ZAP-70(Homo sapiens (Human))
Takeda California

Curated by ChEMBL
LigandPNGBDBM50204290(CHEMBL3979920 | US11077111, Compound IIIa | US2023...)
Affinity DataIC50:  75nMAssay Description:Inhibition of human full length N-terminal GST-tagged ZAP-70 (1 to 619 residues) expressed in baculovirus expression system using ULight peptide as s...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine/threonine-protein kinase PAK 4(Homo sapiens (Human))
Takeda California

Curated by ChEMBL
LigandPNGBDBM50204290(CHEMBL3979920 | US11077111, Compound IIIa | US2023...)
Affinity DataIC50:  76nMAssay Description:Inhibition of human recombinant GST-tagged PAK4 catalytic domain (295 to 591 residues) expressed in baculovirus expression system by Z'-LYTE assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Takeda California

Curated by ChEMBL
LigandPNGBDBM50204290(CHEMBL3979920 | US11077111, Compound IIIa | US2023...)
Affinity DataIC50:  88nMAssay Description:Inhibition of human recombinant His-tagged VEGFR2 cytoplasmic domain (789 to1356 residues) expressed in baculovirus expression system by Z'-LYTE assa...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetToll-like receptor 9(Homo sapiens (Human))
Neuropore Therapies

US Patent
LigandPNGBDBM649721(3-fluoro-2-hydroxy-5-(1-(4- (trifluoromethyl)pheny...)
Affinity DataIC50:  100nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetTyrosine-protein kinase JAK3(Homo sapiens (Human))
Takeda California

Curated by ChEMBL
LigandPNGBDBM50204290(CHEMBL3979920 | US11077111, Compound IIIa | US2023...)
Affinity DataIC50:  114nMAssay Description:Inhibition of human recombinant GST-tagged JAK3 expressed in baculovirus expression system using 5-carboxyfluorescein(FAM)-EEPLYWSFPAKKK-NH2 as subst...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Takeda California

Curated by ChEMBL
LigandPNGBDBM50204290(CHEMBL3979920 | US11077111, Compound IIIa | US2023...)
Affinity DataIC50:  135nMAssay Description:Inhibition of human N-terminal 6His-tagged VEGFR2 (807 to 1171 residues) expressed in Sf9 insect cells using 5-carboxyfluorescein(FAM)-EEPLYWSFPAKKK-...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetToll-like receptor 9(Homo sapiens (Human))
Neuropore Therapies

US Patent
LigandPNGBDBM649750(2-fluoro-6- ((morpholinoimino)methyl)-4- (3-(4-(py...)
Affinity DataIC50:  140nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetToll-like receptor 2(Homo sapiens (Human))
Neuropore Therapies

Curated by ChEMBL
LigandPNGBDBM50570373(CHEMBL4852939)
Affinity DataIC50:  200nMAssay Description:Antagonist activity at human TLR2 expressed in HEK-Blue cells assessed as inhibition of Pam3CSK4-induced TLR2/TLR1 activation by measuring decrease i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetToll-like receptor 2(Homo sapiens (Human))
Neuropore Therapies

Curated by ChEMBL
LigandPNGBDBM50570375(CHEMBL4856507)
Affinity DataIC50:  200nMAssay Description:Antagonist activity at human TLR2 expressed in HEK-Blue cells assessed as inhibition of Pam3CSK4-induced TLR2/TLR1 activation by measuring decrease i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetToll-like receptor 9(Homo sapiens (Human))
Neuropore Therapies

US Patent
LigandPNGBDBM649705(3-fluoro-5-formyl-4-hydroxy- N-(5-(3-(pyrrolidin-1...)
Affinity DataIC50:  200nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Neuropore Therapies

US Patent
LigandPNGBDBM649697(3-fluoro-5-formyl-4-hydroxy- N-(5-phenylthiazol-2-...)
Affinity DataIC50:  200nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetToll-like receptor 6(Homo sapiens)
Neuropore Therapies

US Patent
LigandPNGBDBM649763(8-fluoro-4-hydroxy-3-(2- methoxyethyl)-6-(3-(4- (p...)
Affinity DataIC50:  200nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetPhosphorylase b kinase gamma catalytic chain, liver/testis isoform(Homo sapiens (Human))
Takeda California

Curated by ChEMBL
LigandPNGBDBM50204290(CHEMBL3979920 | US11077111, Compound IIIa | US2023...)
Affinity DataIC50:  226nMAssay Description:Inhibition of human recombinant full length N-terminal GST-tagged PHKG2 expressed in baculovirus expression system by Z'-LYTE assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetToll-like receptor 9(Homo sapiens (Human))
Neuropore Therapies

US Patent
LigandPNGBDBM649747((3-fluoro-4-hydroxy-5-(((4- methylpiperazin-1- yl)...)
Affinity DataIC50:  260nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Neuropore Therapies

US Patent
LigandPNGBDBM649748((3-fluoro-4-hydroxy-5- ((morpholinoimino)methyl) p...)
Affinity DataIC50:  260nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetToll-like receptor 6(Homo sapiens)
Neuropore Therapies

US Patent
LigandPNGBDBM649759(2-fluoro-6-formyl-4-(3-(4- (pyrrolidin-1-yl)phenyl...)
Affinity DataIC50:  300nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetToll-like receptor 2(Homo sapiens (Human))
Neuropore Therapies

Curated by ChEMBL
LigandPNGBDBM50570372(CHEMBL4865889)
Affinity DataIC50:  300nMAssay Description:Antagonist activity at human TLR2 expressed in HEK-Blue cells assessed as inhibition of Pam3CSK4-induced TLR2/TLR1 activation by measuring decrease i...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetToll-like receptor 6(Homo sapiens)
Neuropore Therapies

US Patent
LigandPNGBDBM649710(3-fluoro-5-formyl-4-hydroxy- N-(6-(pyrrolidin-1-yl...)
Affinity DataIC50:  300nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetToll-like receptor 6(Homo sapiens)
Neuropore Therapies

US Patent
LigandPNGBDBM649711(3-fluoro-2-hydroxy-5-(4-(4- (pyrrolidin-1- yl)phen...)
Affinity DataIC50:  400nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetToll-like receptor 6(Homo sapiens)
Neuropore Therapies

US Patent
LigandPNGBDBM649723(5-hydroxy-2-(2-(6-(pyrrolidin- 1-yl)pyridin-3-yl)t...)
Affinity DataIC50:  400nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetToll-like receptor 6(Homo sapiens)
Neuropore Therapies

US Patent
LigandPNGBDBM649747((3-fluoro-4-hydroxy-5-(((4- methylpiperazin-1- yl)...)
Affinity DataIC50:  400nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Neuropore Therapies

US Patent
LigandPNGBDBM649704(3-fluoro-N-(5-(4- fluorophenyl)thiazol-2-yl)-5- fo...)
Affinity DataIC50:  400nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetToll-like receptor 2(Homo sapiens (Human))
Neuropore Therapies

Curated by ChEMBL
LigandPNGBDBM649710(3-fluoro-5-formyl-4-hydroxy- N-(6-(pyrrolidin-1-yl...)
Affinity DataIC50:  400nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Neuropore Therapies

US Patent
LigandPNGBDBM649749((E)-2-fluoro-6-(((4- methylpiperazin-1- yl)imino)m...)
Affinity DataIC50:  410nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetToll-like receptor 6(Homo sapiens)
Neuropore Therapies

US Patent
LigandPNGBDBM649762(8-fluoro-4-hydroxy-3-methyl- 6-(3-(4-(pyrrolidin-1...)
Affinity DataIC50:  430nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetToll-like receptor 6(Homo sapiens)
Neuropore Therapies

US Patent
LigandPNGBDBM649756(2-fluoro-6-formyl-4-(3-(4- (pyrrolidin-1-yl)phenyl...)
Affinity DataIC50:  500nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetToll-like receptor 2(Homo sapiens (Human))
Neuropore Therapies

Curated by ChEMBL
LigandPNGBDBM649721(3-fluoro-2-hydroxy-5-(1-(4- (trifluoromethyl)pheny...)
Affinity DataIC50:  500nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetToll-like receptor 6(Homo sapiens)
Neuropore Therapies

US Patent
LigandPNGBDBM649748((3-fluoro-4-hydroxy-5- ((morpholinoimino)methyl) p...)
Affinity DataIC50:  500nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Neuropore Therapies

US Patent
LigandPNGBDBM649751(3-fluoro-5-formyl-4-hydroxy- N-(3-(4-(pyrrolidin-1...)
Affinity DataIC50:  500nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetToll-like receptor 6(Homo sapiens)
Neuropore Therapies

US Patent
LigandPNGBDBM649757(2-fluoro-6-formyl-4-(3-(4- (pyrrolidin-1-yl)phenyl...)
Affinity DataIC50:  500nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetToll-like receptor 6(Homo sapiens)
Neuropore Therapies

US Patent
LigandPNGBDBM649697(3-fluoro-5-formyl-4-hydroxy- N-(5-phenylthiazol-2-...)
Affinity DataIC50:  500nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Neuropore Therapies

US Patent
LigandPNGBDBM649695(3-fluoro-5-formyl-4-hydroxy- N-(5-phenyl-1,3,4-thi...)
Affinity DataIC50:  500nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetToll-like receptor 6(Homo sapiens)
Neuropore Therapies

US Patent
LigandPNGBDBM649721(3-fluoro-2-hydroxy-5-(1-(4- (trifluoromethyl)pheny...)
Affinity DataIC50:  500nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetToll-like receptor 2(Homo sapiens (Human))
Neuropore Therapies

Curated by ChEMBL
LigandPNGBDBM649747((3-fluoro-4-hydroxy-5-(((4- methylpiperazin-1- yl)...)
Affinity DataIC50:  600nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetToll-like receptor 6(Homo sapiens)
Neuropore Therapies

US Patent
LigandPNGBDBM649751(3-fluoro-5-formyl-4-hydroxy- N-(3-(4-(pyrrolidin-1...)
Affinity DataIC50:  600nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
Displayed 1 to 50 (of 242 total ) | Next | Last >>
Jump to: